237TiP GUIDE.MRD: A Consortium guiding multi-modal therapies against minimal residual disease (MRD) by liquid biopsy to assess implementation of circulating tumor DNA (ctDNA) in clinical practice to improve patient outcomes

Autor: Pantel, K., Lindbjerg Andersen, C., Schuuring, E., Malats, N., Heitzer, E., Vat, L., Kiernan, E., Chin, E., Barrett, J.C., Kapp, J.R., Thomas, M., Gerling, M., Reck, M., Löhr, M., Hofman, P., Hiltermann, J.T.J.N., Alix-Panabières, C., Smit, D.J., Bolisetty, M., Karasarides, M.
Zdroj: In Annals of Oncology October 2023 34 Supplement 2:S276-S277
Databáze: ScienceDirect